The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Benzhydryl-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide ID: ALA4782037
PubChem CID: 44231076
Max Phase: Preclinical
Molecular Formula: C22H17N5O2
Molecular Weight: 383.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NC(c1ccccc1)c1ccccc1)c1cnc(-c2cccnn2)nc1O
Standard InChI: InChI=1S/C22H17N5O2/c28-21(17-14-23-20(26-22(17)29)18-12-7-13-24-27-18)25-19(15-8-3-1-4-9-15)16-10-5-2-6-11-16/h1-14,19H,(H,25,28)(H,23,26,29)
Standard InChI Key: HSPPHMHXWTWUAX-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
10.0380 -22.6846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0552 -21.8676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7707 -21.4693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4689 -21.8922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4558 -22.7092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7404 -23.1033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1844 -21.4939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8868 -21.9168 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1975 -20.6769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3266 -23.0788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3136 -23.8958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5981 -24.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8957 -23.8712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9088 -23.0542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6243 -22.6600 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7838 -20.6523 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9130 -20.2827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9260 -19.4657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2278 -19.0429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2409 -18.2259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9563 -17.8317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6546 -18.2505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6415 -19.0675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6153 -20.7015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3267 -20.3073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0291 -20.7261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0160 -21.5431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3005 -21.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5981 -21.5185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 2 0
7 8 2 0
7 9 1 0
4 7 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
1 10 1 0
3 16 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
18 23 2 0
17 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
24 29 2 0
9 17 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.41Molecular Weight (Monoisotopic): 383.1382AlogP: 3.16#Rotatable Bonds: 5Polar Surface Area: 100.89Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.56CX Basic pKa: 0.51CX LogP: 3.94CX LogD: 3.94Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.55Np Likeness Score: -1.35
References 1. Debenham JS,Madsen-Duggan C,Clements MJ,Walsh TF,Kuethe JT,Reibarkh M,Salowe SP,Sonatore LM,Hajdu R,Milligan JA,Visco DM,Zhou D,Lingham RB,Stickens D,DeMartino JA,Tong X,Wolff M,Pang J,Miller RR,Sherer EC,Hale JJ. (2016) Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia., 59 (24.0): [PMID:28002958 ] [10.1021/acs.jmedchem.6b01242 ]